| Literature DB >> 21827718 |
Astrid Skjesol1, Ingrid Skjæveland, Marianne Elnæs, Gerrit Timmerhaus, Børge N Fredriksen, Sven Martin Jørgensen, Aleksei Krasnov, Jorunn B Jørgensen.
Abstract
BACKGROUND: Infectious pancreatic necrosis virus (IPNV) is an aquatic member of the Birnaviridae family that causes widespread disease in salmonids. IPNV is represented by multiple strains with markedly different virulence. Comparison of isolates reveals hyper variable regions (HVR), which are presumably associated with pathogenicity. However little is known about the rates and modes of sequence divergence and molecular mechanisms that determine virulence. Also how the host response may influence IPNV virulence is poorly described.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21827718 PMCID: PMC3169513 DOI: 10.1186/1743-422X-8-396
Source DB: PubMed Journal: Virol J ISSN: 1743-422X Impact factor: 4.099
Figure 1Cumulative mortality and presence of IPN virus in pancreas and head kidney of Atlantic salmon challenged with two different IPNV strains. A. Percent cumulative mortality is significantly higher in fish infected with NFH-Ar (tank I and tank II indicated with dark and light blue, respectively) than with NFH-El (two tanks indicated with orange or yellow) after bath challenge. B. Viral titers in pancreas from 3-4 fish in duplicate tanks at day 6, day 13 and day 29 post challenge, measured by TCID50/g tissue. C. IPNV VP2 transcript levels relative to levels of NFH-El 29 d.p.i in head kidney measured by qPCR. D. IPNVVP2 Ct-values measured in head kidney from individual fish at day 13 and day 29.
Mutation rates in IPNV genome
| VP1 | VP2 | VP3 | VP4 | VP5 | |
|---|---|---|---|---|---|
| Length bp | 2535 | 1521 | 710 | 679 | 402 |
| Mutations per 1 kb | 14.6 | 15.8 | 19.7 | 7.3 | 17.4 |
| Non-synonymous mutations | 3 | 12 | 9 | 2 | 7 |
| Synonymous mutations | 33 | 12 | 5 | 3 | 0 |
| Ka/Ks | 0.03 | 0.36 | 0.40 | 0.17 |
Figure 2The highest level of sequence changes in VP2 coincided with the region that is regarded as a determinant of virulence. A. A sliding window plot of mutation frequencies, and B. Ka/Ks ratio in VP2 (window length - 50 sites, step size - 10 sites).
Figure 3Sequence analyses of IPNV segment A. A. A schematic presentation of the IPNV genome segment A which encode VP2, VP4, VP3 and VP5. Positions of divergent amino acid are indicated, and the sequences of VP2 and VP5 from the two field isolates NFH-Ar and NFH-El are compared to the non-virulent lab-strain N1 before and after the challenge experiment. B. Sequencing chromatograms showing that amino acids in positions 217, 221 and 247 of VP2 were changing rapidly in cell culture and in challenged fish. The PCR-products sequenced from the NFH-Ar strain changed partially from a TAT motif found in the originally infected fish (origin) to a TTT motif after propagation in CHSE-214 cells for the challenge experiment (input). Virus isolated from the fish after the challenge had a PAA motif (HK d13). C. The NFH-El strain changed from a TAT found in the original material (origin) to a TTT motif after three passages in CHSE-214 cells (input). Virus isolated from the fish after this challenge (HK d29) had a PAA motif like seen in the NFH-Ar challenged fish. D. The ORF of VP5for the NFH-Ar strain changed from a 133 amino acid peptide to a 105 amino acid peptide when a stop codon was introduced in position 106 after the challenge. The NFH-El strain initially had a very short VP5 ORF, only 28 amino acids long, which was maintained after the challenge.
Differentially expressed immune genes between IPNV isolates, as assessed by microarray analyses of head kidney at 13 d p.i.
| Accession | Gene | Isolate NFH-Ar | Isolate NFH-El |
|---|---|---|---|
| GE828737 | Beta-2 microglobulin BA1 | 0.31 ± 0.19 | |
| CX026208 | Beta-2-microglobulin JB1 | 0.37 ± 0.12 | |
| CA043257 | MHC class 1b antigen | 0.16 ± 0.12 | |
| CU070775 | MHC class I heavy chain-1 | 0.21 ± 0.07 | |
| BX857730 | Proteasome subunit beta type 9 | 0.10 ± 0.03 | |
| CU071943 | Galectin 9-1 | -0.06 ± 0.13 | |
| CX035552 | Galectin 9-2 | 0.03 ± 0.11 | |
| CA353586 | Galectin 9-3 | 0.47 ± 0.10 | |
| CA379576 | Galectin like 2 | 0.19 ± 0.12 | |
| CA379898 | Galectin like 1 | -0.24 ± 0.09 | |
| BX079375 | Galectin-3 binding protein | 0.21 ± 0.17 | |
| CA367930 | Interferon inducible protein 1 | 0.76 ± 0.17 | 0.58 ± 0.21 |
| CA363130 | Interferon-induced 35 kDa protein | -0.03 ± 0.06 | |
| CA376422 | Interferon-induced protein 44-2 | 0.17 ± 0.08 | |
| CA381440 | Double-stranded RNA-specific adenosine deaminase | 0.11 ± 0.09 | |
| CA378782 | Tyrosine-protein kinase Jak1-2 | -0.28 ± 0.13 | |
| CA373850 | STAT1 | 0.02 ± 0.11 | |
| CA376536 | Tripartite motif (VRG3) | 0.41 ± 0.12 | |
| CA349577 | Tyrosine-protein kinase SRK2 | -0.32 ± 0.10 | |
| CA361535 | CC chemokine SCYA106 | 0.03 ± 0.12 | |
| CA366435 | CC chemokine SCYA110-1 | -0.91 ± 0.10 | -0.77 ± 0.08 |
| CA374135 | CCL4 | -0.78 ± 0.09 | -0.78 ± 0.12 |
| CA378286 | Interleukin-1 receptor-associated kinase 1-2 | 0.71 ± 0.15 | 0.78 ± 0.13 |
| CA362179 | Interleukin-1 receptor-like protein 2 | -0.37 ± 0.12 | |
| CA361101 | Regulator of G-protein signaling 1-2 | 0.81 ± 0.18 | 0.52 ± 0.22 |
| CF752495 | Transcription factor jun-B-1 | -0.18 ± 0.10 | |
| CA342573 | TNF receptor superfamily member 11B | 0.10 ± 0.14 | |
| CA346166 | Arachidonate 5-lipoxygenase-1 | 0.59 ± 0.07 | 0.78 ± 0.14 |
| BX890112 | Cytochrome P450 2F1 | -1.03 ± 0.04 | -0.94 ± 0.11 |
| EV384586 | Cytochrome P450 2K4 | -1.08 ± 0.07 | -1.06 ± 0.19 |
| CA372428 | Leukotriene B4 receptor 1 | -0.98 ± 0.10 | -1.04 ± 0.12 |
| CA366643 | Prostaglandine D synthase | 0.28 ± 0.21 | |
| CA359451 | C type lectin receptor C | -0.72 ± 0.05 | -0.65 ± 0.17 |
| CA363676 | Complement factor B/C2-B | -0.96 ± 0.08 | -0.88 ± 0.11 |
| BX082584 | Complement factor H-1 | -0.92 ± 0.07 | -0.61 ± 0.12 |
| BX075495 | High affinity Ig Fc receptor I | 0.93 ± 0.29 | 0.20 ± 0.15 |
| CA367288 | Properdin | 1.02 ± 0.16 | 0.89 ± 0.15 |
| CA376803 | Serine protease-like protein-2 | -0.68 ± 0.15 | -0.21 ± 0.15 |
| CR943302 | Tolloid-like protein (nephrosin)-1 | -0.44 ± 0.11 | -1.08 ± 0.30 |
| CA370329 | Lysozyme C precursor | -0.04 ± 0.09 | |
| CA385270 | Granulins | 0.25 ± 0.02 | |
| CF752659 | Ferritin heavy chain-1 | 0.82 ± 0.12 | 0.56 ± 0.24 |
| CA345780 | Lysozyme g-2 | -0.90 ± 0.10 | -0.49 ± 0.36 |
| CX720700 | BCL2/adenovirus E1B protein-interacting | 1.49 ± 0.29 | 0.93 ± 0.19 |
| CA366608 | CASP8 and FADD-like apoptosis regulator | 0.63 ± 0.14 | |
| CA384134 | G1/S-specific cyclin D2 | -0.12 ± 0.31 | |
| CA377697 | Platelet-derived endothelial cell growth factor | 0.72 ± 0.15 | 0.47 ± 0.09 |
| CA376673 | Pre-B cell enhancing factor | 0.28 ± 0.11 | |
Data are log2-ER ± SE. Significant difference between the study groups (t-test, p < 0.05) is indicated with italics.
Figure 4Regulation of immune pathways in response to infection with the two IPNV isolates analyzed by qPCR. Data are mean fold change in head kidney transcript levels +/- SE from infected fish relative to controls calculated by the ΔΔCT method, adjusted for PCR efficiency and normalized against the elongation factor. A. Validation of microarray results by qPCR on selected immune genes presented in Table 2 (n = 6). B. Expression of pattern recognition receptors, MyD88 and PKR analyzed in 8 fish per strain at each time point. C. Expression of genes involved in innate immunity/IFN signaling and sIgM analyzed in 8 fish per strain at each time point.
Figure 5Variations in immune gene expression and virus levels between individuals. Transcript levels of Mx, IFN-γ and IPNV VP2 in head kidney and titers of IPNV in pancreas are shown at individual levels for the two IPNV isolates. The Mx and IFN-γ transcript levels are compared to uninfected control fish, while IPNV VP2 transcripts are compared to the NFH-El group 29d.p.i, IPNV titers were calculated by end point titration and results show TCID50/g tissue. For some individuals the transcript levels were undetected and are thus not presented.
Primers and probes used for qPCR analyses
| Genes | Assay | Primer | Sequence (5'-3') | PCR efficiency | GenBank accession # |
|---|---|---|---|---|---|
| TaqMan | Forward | TGCCCCTCCAGGATGTCTAC | 2.0 | ||
| TaqMan | Forward | TGGGCAGTGTGGATACAAGTG | 2.0 | ||
| TaqMan | Forward | CCTTTCCCTGCTGGACCA | 1.94 | ||
| TaqMan | Forward | AAGGGCTGTGATGTGTTTCTG | 2.0 | ||
| TaqMan | Forward | GATGCTGCACCTCAAGTCCTATTA | 2.0 | ||
| TaqMan | Forward | GACAAAGTTTGCCCTCAGTCTCT | 1.84 | ||
| TaqMan | Forward | ACCAAAACCACTAATGACATCATCTTCA | 1.7 | ||
| TaqMan | Forward | TCTATGGCTGGGATGTCTGGTA | 1.81 | ||
| TaqMan | Forward | ATTTATCCCGGAATCCATGTATCACG | 1.98 | ||
| TaqMan | Forward | GCCAAGATGACCCAGTCCAT | 2.0 | ||
| SybrGreen | Forward | TCGTTGTACTTGTGCTCATTTACAGC | 1,6 | ||
| SybrGreen | Forward | CCAGACCAACAGTGTTCACTTCAGC | 1,84 | ||
| SybrGreen | Forward | GTCCTGTCTATTGCCTTCTCCAACC | 1,76 | ||
| SybrGreen | Forward | CTGCATTGAGTGGCTGAAGA | 1,72 | ||
| SybrGreen | Forward | GACTTCAATTTCCTGCTGGCTA | 1.77 | ||
| SybrGreen | Forward | GACGGTCAGCAGGGTGTACT | 1.97 | ||
| SybrGreen | Forward | CAGAGGTGGGGTTCAATGAT | 1.92 | ||
| SybrGreen | Forward | TTCCTGCATGGACTTGACTG | 1.87 | ||
| SybrGreen | Forward | TAGACATGGCACCATGGACCCTC | 1.81 |